Barclays’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1
| Closed | – | – | 5692 |
|
|
2024
Q4 | $0 | Sell |
1
-7,100
| -100% | -$865 | ﹤0.01% | 5566 |
|
|
2024
Q3 | $4.12K | Sell |
7,101
-31,687
| -82% | -$17.8K | ﹤0.01% | 5043 |
|
|
2024
Q2 | $24K | Sell |
38,788
-61,529
| -61% | -$52K | ﹤0.01% | 4410 |
|
|
2024
Q1 | $258K | Sell |
100,317
-41,470
| -29% | -$101K | ﹤0.01% | 3981 |
|
|
2023
Q4 | $289K | Buy |
141,787
+105,042
| +286% | +$192K | ﹤0.01% | 4235 |
|
|
2023
Q3 | $63.2K | Sell |
36,745
-1,917
| -5% | -$3.4K | ﹤0.01% | 3765 |
|
|
2023
Q2 | $75.4K | Sell |
38,662
-34,013
| -47% | -$79.6K | ﹤0.01% | 3669 |
|
|
2023
Q1 | $202K | Buy |
72,675
+47,280
| +186% | +$135K | ﹤0.01% | 3785 |
|
|
2022
Q4 | $87.6K | Buy |
25,395
+170
| +0.7% | +$485 | ﹤0.01% | 4306 |
|
|
2022
Q3 | $64K | Buy |
25,225
+2,878
| +13% | +$9.16K | ﹤0.01% | 3704 |
|
|
2022
Q2 | $54K | Sell |
22,347
-7,328
| -25% | -$19.2K | ﹤0.01% | 4013 |
|
|
2022
Q1 | $123K | Sell |
29,675
-44,533
| -60% | -$236K | ﹤0.01% | 3694 |
|
|
2021
Q4 | $954K | Buy |
74,208
+37,803
| +104% | +$419K | ﹤0.01% | 2864 |
|
|
2021
Q3 | $393K | Buy |
36,405
+12,539
| +53% | +$114K | ﹤0.01% | 3305 |
|
|
2021
Q2 | $218K | Sell |
23,866
-49,772
| -68% | -$460K | ﹤0.01% | 3512 |
|
|
2021
Q1 | $694K | Buy |
73,638
+63,875
| +654% | +$880K | ﹤0.01% | 2999 |
|
|
2020
Q4 | $38K | Sell |
9,763
-4,068
| -29% | -$12.3K | ﹤0.01% | 4530 |
|
|
2020
Q3 | $37K | Sell |
13,831
-2,553
| -16% | -$9.48K | ﹤0.01% | 4734 |
|
|
2020
Q2 | $109K | Buy |
16,384
+8,121
| +98% | +$54.7K | ﹤0.01% | 4456 |
|
|
2020
Q1 | $48K | Sell |
8,263
-16,963
| -67% | -$142K | ﹤0.01% | 5259 |
|
|
2019
Q4 | $225K | Buy |
25,226
+12,160
| +93% | +$101K | ﹤0.01% | 4947 |
|
|
2019
Q3 | $112K | Sell |
13,066
-3,193
| -20% | -$32.3K | ﹤0.01% | 5393 |
|
|
2019
Q2 | $181K | Sell |
16,259
-3,741
| -19% | -$42.8K | ﹤0.01% | 5208 |
|
|
2019
Q1 | $266K | Buy |
20,000
+15,646
| +359% | +$209K | ﹤0.01% | 4607 |
|
|
2018
Q4 | $67K | Sell |
4,354
-5,646
| -56% | -$108K | ﹤0.01% | 5300 |
|
|
2018
Q3 | $142K | Buy |
+10,000
| New | +$142K | ﹤0.01% | 5269 |
|
Barclays's GRTS Position: Q1 2025 in Review
Barclays sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2025, closing a stake of 1 share.
Barclays first reported a position in GRTS in Q3 2018 and held it in 26 quarters. The position peaked at $954K in Q4 2021. 0 funds tracked by Wall St. Rank hold GRTS as of Q1 2025.
- Barclays reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Barclays sold 1 Gritstone bio, Inc. Common Stock share in Q1 2025.
- Barclays first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 26 quarters.
- Barclays's Gritstone bio, Inc. Common Stock position peaked at $954K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2025.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.